Related Experiment Video
Updated: Nov 4, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Non-competitive interactions between hydroxychloroquine and azithromycin: Systematic density functional, molecular
Mohammed A H Khalafalla1, Chokri Hadj Belgacem1, Ismail Abdelrehim2
1Department of Physics, Faculty of Science, Yanbu, Taibah University, Yanbu, Saudi Arabia.
Hydroxychloroquine (HCQ) and azithromycin (AZTH) do not spontaneously interact in water. Computational studies show they bind to different sites on SARS-CoV-2 proteins, suggesting synergistic potential without compromising efficacy.
Area of Science:
- Computational Chemistry
- Drug Interactions
- Molecular Modeling
Background:
- Hydroxychloroquine (HCQ) and azithromycin (AZTH) are drugs with potential applications against SARS-CoV-2.
- Understanding drug interactions is crucial for optimizing therapeutic strategies.
Purpose of the Study:
- To investigate the non-competitive interaction between HCQ and AZTH using computational methods.
- To elucidate the binding mechanisms of HCQ and AZTH with SARS-CoV-2 targets.
Main Methods:
- Density Functional Theory (DFT) calculations were employed to study molecular interactions.
- Molecular docking simulations were performed to assess binding affinities and sites.
- Thermodynamic parameters like Gibbs free energy and enthalpy were calculated.
Main Results:
- Calculated Gibbs free energy and enthalpy changes were positive, indicating non-spontaneous HCQ-AZTH complex formation in water.
- Docking studies revealed distinct binding sites for HCQ and AZTH on SARS-CoV-2 main protease and ACE2 proteins.
- The combined HCQ-AZTH structure exhibited enhanced electrochemical properties.
Conclusions:
- HCQ and AZTH do not spontaneously form a complex in aqueous media.
- The drugs target different sites on viral and host proteins, suggesting a non-competitive interaction.
- Synergistic effects between HCQ and AZTH are possible, potentially enhancing therapeutic efficacy against SARS-CoV-2 without adverse interactions.
More Related Videos
09:09High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Pharmacokinetics: Drug–Drug Interactions
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
The Equilibrium Binding Constant and Binding Strength
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...